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Abstract
Background: Abortion related deaths as a proportion of maternal mortality appears to have fallen dramatically in
Bangladesh from 5 % in 2001 to 1 % in 2010. Yet complications from menstrual regulation (MR) and unsafe
abortion continue to cause deleterious health, economic and social consequences for women in the country.
Methods: This quasi experimental design study with a baseline (January to December 2008) and an endline survey
(August to October 2009) was conducted in 69 public, private, and NGO sector health facilities in Jessore district of
Bangladesh with the objective of adapting and implementing a set of process indicators, specifically to supplement
the indicators for monitoring emergency obstetric care interventions. At the baseline, we collected retrospective
data from all 69 health facilities that provided MR, legal abortion or post-abortion care (PAC), by reviewing their last
one year’s records. Three months after introducing the safe menstrual regulation and abortion care (SMRAC) model,
endline data was collected. Signal function (critical services that facilities must perform in order to prevent and treat
abortion complications) analysis was used to characterize facilities as providing basic care, comprehensive care, or
neither. Facility mapping, and records on services provided and complications treated were used to further
characterize service availability and to describe service use and quality.
Results: No facilities fulfilled criteria for ‘comprehensive’ care at either the baseline or end line while only one met
the ‘basic’ criteria during the endline of the project. Recommended uterine evacuation technology, manual vacuum
aspiration (MVA) was used for 100.0 % of MR clients but only for 8.0 % or fewer PAC patients. MR clients were 37.5
times more likely than PAC patients to leave facilities with a contraceptive method (75.0 % vs. 2.0 %).
Conclusion: Persistent use of older uterine evacuation technologies was observed when recommended techniques
were widely available in the facilities. Notable gaps were identified in providing post-abortion contraceptive services
for women treated for PAC. By systematic implementation of the SMRAC model, health systems can track and
measure progress and gaps in their implementation and identify strategies for further reduction of abortion-related
morbidity and mortality in Bangladesh.
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Background
Globally, slow progress has been made toward Millen-
nium Development Goal 5 (MDG 5) of reducing mater-
nal mortality ratio by 75.0 % between 1990 and 2015.
Many countries, particularly those with low resources,
have not met the necessary 5.5 % annual decline neces-
sary to be on track for the 2015 deadline [1]. Nonethe-
less, in Bangladesh, maternal mortality ratio has
decreased by 66.0 % in the last 20 years, from an esti-
mated 574 to 194 per 100,000 live births between 1990
and 2010 [2]. The annual abortion-related deaths per
100,000 women of reproductive age decreased by 87.0 %
from an average of 17 in the years 1976–1985 to an
average of 2 for the years 1996–2005 in Matlab, a rural
area of Bangladesh [3]. The Bangladesh Maternal Mor-
tality Surveys from 2001 to 2010 recorded that abortion-
related mortality as a percent of all maternal deaths fell
from 5 to 1 % [2]. Longitudinal data suggest that reduc-
tions in abortion-related mortality – a cause of 13 % of
maternal mortality globally – may have contributed to
this decline [4]. With its current annual rate of decline
in maternal mortality of 5.5 %, Bangladesh appears to be
one of the few countries on track to meet the primary
target of MDG 5 [2]. Yet women who do not want to be-
come pregnant and do not have access to contraception
are at risk of unplanned pregnancy and unsafe abortion
[5]. This result in complications arising from MR proce-
dures and unsafe abortion continue to cause deleterious
health, economic and social consequences not only for
the women but also for the society as a whole, both in
the short term and in the long run [6].
Abortion is illegal in Bangladesh except only to save
the life of the woman. Since the 1970s, Bangladesh has
maintained a menstrual regulation (MR) program, which
is defined as an interim method of establishing non-
pregnancy in women at risk of being pregnant [7]. MR
has an advantage in countries where abortion is legally
banned because it can be conducted without a confirma-
tory pregnancy test, within 10 weeks of the beginning of
the last menstrual period by family welfare visitors
(health service providers having at least ten years of for-
mal schooling and 18 months of training in family plan-
ning and maternal and child health care, and additional
training specifically in MR) and within 12 weeks of a
missed menstrual period by medical doctors [8, 9]. Al-
though MR services have been decentralized, estimates
showed that the incidence of induced abortion was the
same as that of MR in 2010, (647,000 and 653,000 re-
spectively) which implies that the demand for MR ser-
vices are not being met [10]. Also there were 231,400
women treated for complications of induced abortions
in the same year and another 341,000 complicated cases
did not get any medical care [10]. Additionally, an esti-
mated 78,000 complications from MR were found which
indicate that the quality of clinical services needs to be
strengthened [10].
Over the last decade, a set of tools and indicators have
been used to monitor emergency obstetric care (EmOC)
interventions for reducing maternal deaths. These UN
EmOC indicators include treatment of abortion compli-
cations [5, 11]. However, essential preventive means to
reduce unsafe abortion are not represented. A recent
study in Bangladesh showed that in the public sector, a
system for collecting data on MR and PAC exists, but
underreporting is common, while in the private sector,
there is limited or no data [6]. Although this study gave
estimates for MR and PAC in one point in time, it
pointed out that having consistent and comparable data
on a continuous basis would help the government in
identifying gaps in the health system that influence
provision of MR and abortion for legal indications [6].
As for the health system in Bangladesh, in the public
sector, the largest health service provider of the country
is the Ministry of Health & Family Welfare (MoH&FW).
There are two major implementation wings under the
MoH&FW- the Directorate General of Health Services
(DGHS) and the Directorate General of Family Planning
(DGFP). The DGHS is responsible for implementation
of all public health programmes in the country including
emergency preparedness and response (EPR) programme.
The DGFP is responsible for implementing family plan-
ning (FP) programmes and providing FP related technical
assistance to the MoH&FW [12, 13].
To address the gap on consistent and continuous data
on MR and PAC, we conducted this study to adapt and
implement a set of process indicators, based on the safe
abortion care (SAC) model, developed by Ipas, a repro-
ductive rights non-profit organization based in the US,
specifically to supplement the tools and indicators for
monitoring emergency obstetric care interventions. In
this study, The SAC model was validated and adapted as
the safe menstrual regulation and abortion care (SMRAC)
model [9, 14] with the objective of assessing the feasibility,
acceptability and utility of the SMRAC model in Jessore
district of Bangladesh. We also documented the availabil-
ity, utilization, and quality of MR and abortion services
over time, and highlighted elements of care in need of
quality improvement.
Methods
This quasi experimental design study was conducted in
Jessore, a district in the southwest part of the country,
with a baseline (January to December 2008) and an
endline survey (August to October 2009). All 74 registered
health facilities [public (n = 44), private-for-profit (n = 22),
and NGO not-for-profit (n = 8)] in Jessore, that provided
MR, legal abortion, and/or PAC services were enlisted in
the project. Among the 44 public sector facilities 36 were
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under the management of the Directorate General of
Family Planning (DGFP) and eight were under the Direct-
orate General of Health Services (DGHS) of the Ministry
of Health & Family Welfare (MoH&FW). Two of the pub-
lic sector facilities including district hospital and maternal
and child welfare centre (MCWC), situated at district
level, provided secondary level of health care and the
remaining 42 facilities including upazilla health complexes
(UHC) placed at upazilla/sub-district level, union health
and family welfare centres (UH&FWC) and family welfare
centres (FWC) placed at union level, provided primary
level of health care.
The SMRAC model focuses on three service areas es-
sential for reducing abortion-related maternal mortality:
MR and abortion for legal indications, treatment for
abortion complications (complications of spontaneous
abortion and MR as well as complications of unsafe in-
duced abortion), and contraceptive services for MR and
PAC patients. The SMRAC model comprises of seven
indicators and several signal functions (defined as critical
services that facilities must provide to prevent and treat
complications due to MR & abortion).
We assessed availability and distribution of SMRAC
services by determining the 10 signal function perform-
ance at each facility (listed in Table 1). Facilities that of-
fered all 6 basic signal functions in the previous
3 months were considered as “basic” and facilities that
performed all 10 signal functions were considered as
“comprehensive.” The 6 basic signal functions are attain-
able for health centers and include services for first tri-
mester induced abortion and treatment of complications.
The additional 4 comprehensive signal functions are more
consistent with hospitals’ capacity and include surgery and
blood transfusion as well as second trimester abortion
care. The SMRAC indicators (listed and defined in Table 2)
were used to monitor facility availability, distribution, ser-
vice utilization, and quality of care [5, 9, 14].
Data collection
The project was implemented in five phases:
Phase 1: Development and adaptation of study mate-
rials to be appropriate to the country setting; reviewed
and revised materials based on stakeholder recommen-
dations; pretested study tools; revised the baseline and
monitoring tools based on pretest results. (January-
February)
Phase 2: Baseline data was collected from facility rec-
ord book for the period January-December 2008 (sec-
ondary data). Data were analyzed and preliminary results
were shared with policy makers and representatives of
participating facilities at an orientation workshop.
(March-April)
Phase 3: Training of staffs from participating facilities
on the new SMRAC model and introduction of the tool
in all selected facilities. Regular visit of project staff to
the facilities for monitoring and helping the service pro-
viders to use the SMRAC model (May-July 2009).
Phase 4: Endline data collection by project staff
(August-October 2009) from the new SMRAC model
(primary data).
Phase 5: Comparative data analysis of baseline and
endline data; findings shared to local and national stake-
holders from the public, private, and NGO health
facilities.
Data analysis
Data were entered into Microsoft Excel 2007 and cross-
checked against original entry forms. All data were con-
verted into IBM SPSS (20 version) for analysis. The
SMRAC indicators were calculated for 2 periods: a year‐
long baseline data (January to December 2008) and end-
line data (August-October 2009). Results were reported
for each SMRAC indicator. Signal function analysis was
done to characterize facilities as providing basic care,
comprehensive care, or neither. Facility mapping, and
records on services provided and complications treated
were analyzed to further characterize service availability
and to describe service use and quality. The Chi-square
test was used to compare baseline and endline indicators
for private, public, and NGO sector health facilities. Sig-
nificance was evaluated at P < 0.05.
Table 1 Signal functions for safe menstrual regulation and abortion care (SMRAC)
Signal functions for basic SMRAC services Signal functions for comprehensive SMRAC services
● Administer essential antibiotics Perform all basic functions plus
● Administer intravenous fluids
● Administer oxytocics ● Perform safe, legal abortion for uterine size >12 weeks, for all legal
indications
● Perform removal of retained products for uterine size ≤12 weeks ● Perform removal of retained products for uterine size >12 weeks
● Perform MR for uterine size ≤10 weeks and/or safe, legal abortion
(≤12 weeks)
● Perform blood transfusion
● Provide post-MR and post-abortion contraception ● Perform laparotomy
Table adapted from Healy et al. [9], originally adapted from UN guidelines (Maine et al. [14])
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Ethical approval
The study was approved by the Institutional review
board (IRB) of International Centre for Diarrhoeal
Disease Research, Bangladesh (icddr,b).
Results
We report findings from the implementation of the seven
SMRAC indicators, first in terms of availability and
distribution of services and then in terms of use and qual-
ity of services. Among the 74 participating facilities, five
facilities (4 private and 1 NGO) dropped out before pro-
ject completion. Owners of the four private facilities felt
that participation in the project was time-consuming and
not beneficial to their business and the NGO clinic had
closed due to lack of funds. Finally, at the endline, data
from 69 health facilities has been presented.
Table 2 Seven Indicators for measuring SMRAC
SMRAC indicators Definition Recommendation
Are enough facilities providing SMRAC services?
1. Amount of SMRAC services available Number of facilities providing basic and
comprehensive SMRAC
For every 500,000 population: 5 SMRAC
facilities, at least 1 of which offers
comprehensive SMRAC
Are SMRAC services well-distributed?
2. Distribution of SMRAC facilities Number of facilities providing basic and
comprehensive SMRAC in sub national areas
Minimum: 100 % of sub-national areas have
adequate level of SMRAC as recommended
in indicator 1
What proportion of services for women with obstetric complications are services for MR/abortion complications?
3. Proportion of women treated for obstetric
complications that are MR/abortion related
Numerator: number of women with MR/abortion
complications treated at a facility in a given
period;
Over time, a declining percentage of women
with abortion/MR complications
Denominator: number of all women with
obstetric complications treated at facility in the
same time period
How common are serious abortion/MR complications?
4. Proportion of women treated for MR/abortion
complications that are serious
Numerator: number of women with serious MR/
abortion complications treated at a facility in a
given period; Denominator: number of all women
with any MR/abortion complications treated at
facility in the same time period
Over time a declining percentage of women
with serious MR/abortion complications
To what extent are MR and safe, legal abortion being provided?
5. Proportion of women who receive MR and
safe, legal abortion among all women receiving
MR/abortion care
Numerator: number of women receiving MR and
safe, legal abortion procedures at a facility in a
given time period
Over time, a shift towards a higher
proportion of women receiving MR and safe,
legal abortion
Denominator: number of all women receiving MR
and abortion-related services in facility in the
same time period
Recommended level: Approaching 100 %
Are appropriate technologies being used?
6. Proportion of uterine evacuations performed
with appropriate technology
Numerator: number of uterine evacuation
procedures performed with appropriate
technology at facility in a given period.
Over time, a shift toward a higher proportion
of procedures performed with appropriate
technology as per WHO recommendationsa
Denominator: number of all uterine evacuation
procedures performed at facility within the same
time period
Recommended level: 100 %
Are women who have received MR or safe, legal abortion or treatment for MR/abortion complications provided contraception before being discharged
from a facility?
7. Proportion of women receiving MR, safe, legal
abortion, or treatment for MR/abortion
complications who obtain contraception before
leaving facility
Numerator: number of women receiving MR, safe,
legal abortion or treatment for MR/abortion
complications who obtain contraception before
leaving facility
At least 60 % of all women receiving MR/
abortion services accept contraception
Denominator: number of women receiving MR,
safe, legal abortion, or treatment for MR/abortion
complications in facility in the same time period.
Adapted from Healy et al. [9]
aWHO has provided evidence-based guidance on the preferred methods of uterine evacuation for different stages of pregnancy [17]
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Availability and distribution of SMRAC services
Indicator 1. Are enough facilities providing SMRAC services?
With a population of 2,469,680 [15], Jessore is recom-
mended to have a minimum of 20 basic facilities and five
comprehensive facilities. From all the participating facil-
ities, only one private hospital met the basic SMRAC
criteria during the endline data collection period and
none of the facilities met the criteria to perform all ten
signal functions in the endline (Table 3). Four facilities
reported to providing eight to nine signal functions. One
of these facilities—the district hospital—was docu-
mented as providing eight of the ten signal functions.
Each of the individual basic signal functions was offered
at a minimum of 25 facilities. Three of the four compre-
hensive signal functions were offered at 19 or more facil-
ities though performance of safe, legal abortion for
gestations over 10 weeks was recorded at a maximum of
only 4 facilities (Table 3).
Indicator 2. Are SMRAC facilities well distributed?
Jessore is divided into 8 upazilas/sub-districts; the dis-
trict hospital is located in the sadar (town center) upa-
zila. The other seven upazilas has multi-bedded UHCs;
five of which has both functioning health and FP wing,
whereas two of the UHCs (Chowgacha and Bagharpara)
have only the health wing (no FP wing). The 30 FWCs
and UH&FWCs are well-distributed throughout the dis-
trict and provide MR and contraceptive services. Private
and NGO health facilities were scattered less evenly
throughout the study area (Fig. 1).
Use of SMRAC services
Indicator 3. What proportion of services for women with
obstetric complications are services for MR/abortion
complications?
Over the SMRAC project period, within a month, an
average of 179 women was admitted with obstetric com-
plications that were originally caused due to MR/abor-
tion complications. At baseline, 51 % of the obstetric
complications were identified as abortion-related which
decrease to 29 % at the endline reflects a reduction in
the abortion complication caseload and a substantial in-
crease in the total obstetric complication caseload
(Table 5). This was due to proper categorization of the
cases and accurate record keeping using the SMRAC
model. Overall, the proportion of abortion cases among
all obstetric complications was higher in private facilities
than NGO or public facilities (Table 4).
Indicator 4. How common are MR/abortion related severe
complications?
Severe complications are defined as those that are or
can quickly become life-threatening if not treated imme-
diately and includes shock, severe vaginal bleeding,
intra-abdominal injury, and sepsis [16, 17]. Over the two
periods of measurement, data for the indicator did not
demonstrate any trend. During the baseline 13 % of all
cases with MR/abortion complications were considered
severe, while during endline, the percentage went down
to 11 % (Table 4). Death due to severe complications
was not captured in the study.
Table 3 Signal functions provided by health facilities in the study area
Signal function Baseline Endline
(n = 74) (n = 69)
FWC MCWC UHC Dist.
Hosp.
Private Total FWC MCWC UHC Dist.
Hosp.
Private Total
N = 30 N = 1 N = 12 N = 1 N = 30 N = 74 N = 29 N = 1 N = 12 N = 1 N = 26 N = 69
Administration of antibiotic 0 1 7 1 21 30 0 1 7 1 20 29
Administration of intravenous fluid 0 1 7 1 22 31 1 1 7 1 19 29
Administration of uterotonics 0 1 7 1 23 32 0 1 7 1 20 29
Removal of retained products (≤12 weeks) 0 0 8 1 18 27 0 0 7 1 18 26
Post-procedure contraception 23 1 4 0 4 32 24 1 5 0 6 36
MR (≤10 weeks) and/or safe, legal abortion
(≤12 weeks)
28 1 4 0 6 39 25 1 5 0 6 37
Basic SMRAC facilities (20 recommended:
4 per 500,000 population)
0 0 0 0 0 0 0 0 0 0 1 1
Removal of retained products (>12 weeks) 0 0 6 1 13 20 0 0 6 1 15 22
Blood transfusion 0 0 4 1 18 23 0 0 4 1 19 24
Laparotomy 0 0 2 1 18 21 0 0 2 1 16 19
Safe, legal abortion (>12 weeks) 0 0 0 0 1 1 0 0 2 1 1 4
Comprehensive SMRAC facilities (5 recommended:
1 per 500,000 population)
0 0 0 0 0 0 0 0 0 0 0 0
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Indicator 5. To what extent are MR and safe, legal abortion
being provided?
Findings from the study showed that MR and safe, legal
abortion (abortion that needs to be done to save the life of
the woman) made up the majority (75–77 %) of abortion-
related care (Table 4). NGOs performed the majority of
safe MR procedures (93 % in the endline) among women
receiving abortion services, followed by public facilities
(69 %) and private facilities (33 %) (Table 4). Only 8 legal
abortions were recorded during the project period. No
temporal trends in this indicator were detected.
Quality of SMRAC services
Indicator 6. Are appropriate technologies being used?
Manual vacuum aspiration (MVA), a safe and effective
method of abortion that involves evacuation of the uterine
contents by the use of a hand-held plastic aspirator. It is ap-
propriate for treatment of incomplete abortion for uterine
sizes up to 12 weeks from the last menstrual period (in-
cluding miscarriage, spontaneous abortion and removal of
retained products from an induced abortion), first-trimester
abortion (menstrual regulation) and endometrial biopsy.
Compared to the sharp-curettage method of abortion, use
of MVA requires less cervical dilatation and is associated
with less blood loss, shorter hospital stays and a reduced
need for anesthetic drugs. Vacuum aspiration methods
(either manual or electric vacuum aspiration) are recom-
mended over sharp curettage by the World Health
Organization [18]. Considering all abortion-related uterine
evacuations, the recommended technology, MVA was
used 77–81 % of the time. A disparity in the appropriate-
ness of technology used was revealed between MR care
and PAC services. As shown in Table 5, recommended
technology was used for all the MRs performed over the
study periods (baseline and endline). In stark contrast,
only 8 % of the abortion complication patients were
treated with appropriate technology (MVA) in the baseline
and less than 1 % in the endline; the remaining were
mostly treated with dilatation & curettage (D&C). By the
endline, majority of the NGOs (94 %) were providing uter-
ine evacuation with recommended technology compared
to public (67 %) and private (33.3 %) facilities (Table 4).
Indicator 7. Are women who have received MR, safe legal
abortion or treatment for abortion complications provided
contraception before discharge?
The aggregated data show that at the beginning of the
SMRAC project only 50 % of MR clients and women
Fig. 1 Distribution of health facilities in study area, Jessore-2009
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Table 4 Safe menstrual regulation and abortion care indicators (Indicators 3–7)
Indicator 3 Baseline End line Total p-value
Abortion-related complications as a percentage of obstetric complications (Jan to Dec 2008) (Aug to Oct 2009) (sig. in change from
baseline to endline)
NGO (%) 54.12 26.42 45.66 0.000
368/680 79/299 447/979
Private (%) 68.08 36.30 57.00 0.000
561/824 200/551 761/1335
Public (%) 44.16 24.56 38.79 0.000
1062/2405 223/908 1285/3313
Indicator 4
Serious abortion-related complications as a percentage of
all abortion-related complications by type of facility
NGO (%) 0.27 10.13 2.01 0.000
1/368 8/79 9/447
Private (%) 23.53 9.00 19.71 0.000
132/561 18/200 150/761
Public (%) 11.21 13.00 11.52 0.4220
119/1062 29/223 148/1285
Indicator 5
Proportion of all women receiving abortion services who receive
MR or safe, legal abortions
NGO (%) 92.92 92.94 92.92 0.990
4829/5197 1040/1119 5869/6316
Private (%) 1.23 33.33 12.33 0.000
7/568 100/300 107/868
Public (%) 57.47 68.94 60.03 0.000
1435/2497 495/718 1930/3215
Indicator 6
Proportion of uterine evacuation procedures performed with
recommended technology
NGO (%) 95.36 94.93 95.28 0.531
4829/5064 1048/1104 5877/6168
Private (%) 4.66 33.67 14.56 0.000
27/579 101/300 128/879
Public (%) 67.17 67.36 67.22 0.964
1543/2297 487/723 2030/3020
Indicator 7
Proportion of women receiving MR or abortion services who obtained
contraception before leaving the facility
NGO (%) 58.40 89.10 63.84 0.000
3035/5197 997/1119 4032/6316
Private (%) 0.00 29.67 10.25 0.000
0/568 89/300 89/868
Public (%) 45.33 58.22 48.21 0.000
1132/2497 418/718 1550/3215
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treated for abortion-related complications were recorded
as having received contraceptive services (Table 4). Over
the course of the project this increased to 70 %. A closer
look at the data showed that only nine of 69 facilities re-
ported consistent increases in provision of post-MR or
post-abortion contraceptive services. By the endline,
NGO facilities provided women with more contracep-
tives (89 %) than public (58 %) and private (29.7 %) facil-
ities (Table 4).
Over the data collection periods, 75 % of MR clients
were recorded as having left the facility with a contra-
ceptive method, whereas only 2 % of PAC patients were
recorded as acceptor of a contraceptive method; MR cli-
ents were 37.5 times more likely than PAC patients to
leave facilities with a contraceptive method (75 % vs.
2 %) (Table 5). An additional 13 % of PAC patients were
referred to another facility for contraceptive services.
Discussion
Implementation of the SMRAC model in Jessore has
provided evidence that to meet the SMRAC recommen-
dations, the district needs more facilities that offer six
basic and ten comprehensive signal functions. However,
it was observed that elements of services were more
available than the SMRAC basic and comprehensive sig-
nal function indicators suggest. The current distribution
of health facilities is appropriate, but many require im-
provements in delivering basic and comprehensive care.
Results from the implementation of indicator one sug-
gested that Jessore needs 19 additional basic SMRAC fa-
cilities and five comprehensive SMRAC facilities.
Based on the country’s existing health system, post
abortion care (PAC) services are offered in the health
wing of the Upazila Health Complex (UHC) and referred
to the family planning (FP) wing of the same health
complex for contraceptive services. As a result, the
health wing of each UHC consistently provided the first
four of the six basic signal functions, and the FP wing
consistently provided the remaining two: MR and post-
MR/PAC contraceptive counseling and services. There is
no system of follow-up in the health wing to track
contraceptive acceptance among this group of patients,
as the FP wing maintains separate records. If there was
no administrative division between the health and family
planning wings, five UHCs likely could become compre-
hensive SMRAC facilities.
The present study showed that, only one private hos-
pital met the basic SMRAC criteria during the endline
data collection period and none of the facilities met the
comprehensive SMRAC criteria either in the baseline or
endline. One of the facilities, the district hospital was
found as provider of the eight signal functions. The two
missing signal functions were: contraceptive acceptance
for PAC patients and MR services delivery with associ-
ated contraceptive services. Both of these services were
provided by one NGO, RHSTEP (Reproductive Health
Services Training and Education Program, the only
NGO which is permitted by the Government of
Bangladesh to perform its activities in 13 public medical
college hospitals and nine district hospitals) [19] on the
district hospital campus and appear as services provided
by the NGO sector; even though the PAC patients were
referred to RHSTEP from the district hospital. Addi-
tionally, if staff at the union level, who are assigned to
provide MR and post-MR contraception could be simul-
taneously trained, equipped and authorized to provide
antibiotics, IV fluids, and uterotonics, to remove
retained products and to refer clients with severe com-
plications to the appropriate level of care, then 30 well-
distributed FWCs and UH&FWCs of the study area
could become basic SMRAC facilities.
Though MR and PAC services were found available in
Jessore but MR care meets quality indicators than the
PAC services. Disaggregation of contraception provision
data by MR clients and PAC patients revealed another
disparity in the quality of care received by these two
groups. A large number of MR clients (75 %) left the fa-
cility with a contraceptive method; while only 2 % of the
PAC patients received any contraceptive method during
leaving the facility and another 13 % were referred to
other facility for contraceptive services. It is possible that
additional patients were referred for or supplied with a
family planning method without a record of that
referral.
The SMRAC model helped in identifying important
gaps in the care women receive, notably the absence of
contraceptive services for women treated for PAC and
the persistent use of D&C for uterine evacuation when
the recommended improved technologies (MVA) are
widely available in Bangladesh. The striking difference in
technology used observed in this study implies a role for
targeted capacity building at the facilities. The high
Table 5 Contraceptive acceptance following MR and PAC during the project period
Case
definition
Number of patients /clients Received FP methodsa Received FP referralb Total receiving FP referral or supplies
No. % No. % No. %
Care for MR 9671 7233 75 26 0.3 7259 75
Care for PAC 3067 69 2 405 13 474 15
aDefined as leaving the facility with a contraceptive method
bDefined as referred to another facility for contraceptive services
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numbers of abortion complications identified indicates a
need to explore means of reducing unwanted pregnancies
and unsafe abortions by increasing access to contraception
and MR. Implementation of the SMRAC model also dem-
onstrated the benefits of improved reporting by highlight-
ing areas in need of service delivery improvement.
Findings showed that uptake and continued use of
SMRAC model by the majority of facilities was encour-
aging. Although the research was an attempt to measure
the comprehensiveness and quality of the care available in
the area, it implicitly assumes that monitoring will result
in improvements in services, and the analysis attempts to
identify any such impacts. While many providers
expressed positive feedback for the SMRAC model and its
impact on their record-keeping– including several WHO
attributed enhanced capacity for monitoring, evaluation,
performance, and quality enhancement through the
model, but some expressed inability to use the model due
to limits on time or excessive pre-existing workload. Sev-
eral private clinics expressed concern that use of the
model would not prove beneficial to their business or
profit. Many providers suggested integration of SMRAC
models with government-led monitoring and evaluation.
Study limitations
The study has several limitations. First, there is the possi-
bility that data were misclassified during the early stages
of SMRAC implementation. Several dramatic shifts were
observed in reported service delivery during the project
period. These shifts may have more to do with increased
familiarity with the SMRAC data collection process than
with changes in service delivery. Second, the SMRAC in-
dicators were developed for efficient implementation. The
quality of care indicators have the advantage of ready
quantifiability, however they are not complete measures of
quality of care. For example, they do not include aspects
of care such as client-provider interaction, level of skills
that the providers possess, or the proportion of women
who were rejected from MR services which can substan-
tially influence accessibility of care and service delivery
equity. These indicators can be included in the revised
SMRAC model to better capture the quality of care issues.
Third, the monitoring mechanisms were in effect for too
short a time to expect much change in the facilities, and
the baseline data were not comparable to the monitoring
data in some respects. Additionally, there was no compari-
son group of health facilities in which the SMRAC model
was not being implemented. Furthermore, conducting the
study in only one district may have made the findings less
generalizable.
Conclusion
Globally unsafe abortion is a leading contributor to ma-
ternal morbidity and mortality even though means of
prevention are well known and accessible. Data suggest
that Bangladesh has made progress in reducing maternal
mortality due to unsafe abortion and increased access to
MR along with emergency obstetric care has been shown
to contribute to this reduction [20]. Implementation of
the SMRAC model has provided details of the health
system strategies in place that likely have contributed to
this achievement. Additionally the SMRAC model has
highlighted gaps that if addressed could yield further re-
ductions in abortion-related morbidity and mortality.
Hence monitoring the availability, utilization, and quality
of MR and PAC services using the SMRAC model will
help identify whether these services are reaching recom-
mended standards so that further reductions in the
MMR can be achieved.
Recommendations
Analysis from this study provides valuable insights into char-
acteristics of the health system of the country that could
have identified steps and can contribute to a further reduc-
tion in abortion-related morbidity and mortality. Findings
from the study suggests following recommendations:
 Further research on scaling up the SMRAC model
in both intervention and comparison areas in several
districts of Bangladesh can be designed and
implemented to improve the quality of record
keeping and data availability.
 Supportive supervision regarding use of the SMRAC
model can be encouraged at the facility level, while
capacity building interventions to train in statistical
analysis or providing statistical support may improve
sustainability of this progress. Translation of all
monitoring and evaluation tools into local language
(Bengali) may be a particularly important step.
 Enhanced collaboration among the health and FP
wings in the public sector, and between public,
private, and NGO sectors could facilitate the
implementation of improved post-procedure
contraception service delivery, particularly for
abortion complication patients.
 Use of evidence-based, appropriate technology for
all procedures particularly for abortion complication
patients should be ensured. Targeted interventions
to modulate facility preferences may be particularly
productive toward this end.
 Service providers need to be motivated to achieve
the required standards of the SMRAC Model. The
Pay for Performance (P4P) model that consists of
performance based incentives [21] could have the
potential to entice service providers to perform to
reach targets within a stipulated time.
 Quality assurance groups (QAGs) including
specialists from Medical College Hospital or District
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Hospital and representative of professional body
need to be formed to assess service providers’
performance in terms of quality and quantity as
well as provide supportive feedback to motivate
staff to reach SMRAC recommended levels of
performance [21].
By systematic implementation of the SMRAC model,
health systems can track and measure progress and gaps
in their implementation and identify strategies for fur-
ther reduction of abortion-related morbidity and mortal-
ity in Bangladesh.
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